This month’s “Virtual Lecture” highlights the clinical diagnosis and management of thrombotic microangiopathy, including a summary of the testing modalities that guide diagnosis and management. The utility of genetic testing as it relates to complement testing for thrombotic microangiopathy also will be presented.
Length of video: 58 minutes
Ann Moyer, M.D., Ph.D.
Associate Professor of Laboratory Medicine and Pathology
Assistant Professor of Pharmacology
Division of Laboratory Genetics and Genomics
Mayo Clinic, Rochester, Minnesota
Meera Sridharan, M.D., Ph.D.
Assistant Professor of Medicine and Oncology
Division of Hematology
Mayo Clinic, Rochester, Minnesota
Maria Alice Willrich, Ph.D.
Associate Professor of Laboratory Medicine and Pathology
Division of Clinical Biochemistry
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.
1. Watch the video.
2. Complete the post-test and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Credit expires 7/26/2025.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: mcleducation@mayo.edu